About scPharmaceuticals
scPharmaceuticals is a company based in Lexington (United States) founded in 2013 was acquired by MannKind Corp in August 2025.. scPharmaceuticals has raised $78.75 million across 4 funding rounds from investors including MannKind Corp, Sun Pharma and Orbimed. The company has 164 employees as of December 31, 2024. scPharmaceuticals offers products and services including FUROSCIX. scPharmaceuticals operates in a competitive market with competitors including Valeritas, Crossject, Incline Therapeutics, VeraDermics and CeQur, among others.
- Headquarter Lexington, United States
- Employees 164 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Scpharmaceuticals Inc.
-
Annual Revenue
$36.33 M167.28as on Dec 31, 2024
-
Net Profit
$-85.15 M-55.35as on Dec 31, 2024
-
EBITDA
$-64.63 M-18as on Dec 31, 2024
-
Total Equity Funding
$78.75 M (USD)
in 4 rounds
-
Latest Funding Round
$46.96 M (USD), Series B
Jan 06, 2017
-
Investors
MannKind Corp
& 5 more
-
Employee Count
164
as on Dec 31, 2024
-
Acquired by
MannKind Corp
(Aug 25, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of scPharmaceuticals
scPharmaceuticals is a publicly listed company on the NASDAQ with ticker symbol SCPH in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of scPharmaceuticals
scPharmaceuticals offers a comprehensive portfolio of products and services, including FUROSCIX. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treats heart failure and kidney disease via subcutaneous delivery.
Funding Insights of scPharmaceuticals
scPharmaceuticals has successfully raised a total of $78.75M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $46.96 million completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $47.0M
-
First Round
First Round
(26 Mar 2014)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2017 | Amount | Series B - scPharmaceuticals | Valuation | Orbimed , Sun Pharma | |
| Sep, 2016 | Amount | Series A - scPharmaceuticals | Valuation |
investors |
|
| Feb, 2016 | Amount | Series A - scPharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in scPharmaceuticals
scPharmaceuticals has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include MannKind Corp, Sun Pharma and Orbimed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Venture capital fund backed incubator focused on the healthcare startups
|
Founded Year | Domain | Location | |
|
Life science companies are funded through venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by scPharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - scPharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Scpharmaceuticals Comparisons
Competitors of scPharmaceuticals
scPharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Valeritas, Crossject, Incline Therapeutics, VeraDermics and CeQur, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Wearable insulin patch pumps are developed for transdermal delivery.
|
|
| domain | founded_year | HQ Location |
Needle-free self-injectable drugs
|
|
| domain | founded_year | HQ Location |
Hospital-focused specialty pharmaceuticals are developed for acute pain management.
|
|
| domain | founded_year | HQ Location |
Drug-delivery platforms for pediatric wart treatments are developed.
|
|
| domain | founded_year | HQ Location |
Wearable insulin delivery patches are developed for mealtime dosing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Scpharmaceuticals
Frequently Asked Questions about scPharmaceuticals
When was scPharmaceuticals founded?
scPharmaceuticals was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is scPharmaceuticals located?
scPharmaceuticals is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
Is scPharmaceuticals a funded company?
scPharmaceuticals is a funded company, having raised a total of $78.75M across 4 funding rounds to date. The company's 1st funding round was a Series A of $3.6M, raised on Mar 26, 2014.
How many employees does scPharmaceuticals have?
As of Dec 31, 2024, the latest employee count at scPharmaceuticals is 164.
What is the annual revenue of scPharmaceuticals?
Annual revenue of scPharmaceuticals is $36.33M as on Dec 31, 2024.
What does scPharmaceuticals do?
Provider of a device for subcutaneous drug delivery for the treatment of bacterial infections and heart failure. The company has developed a device called sc2Wear Pump that facilitates subcutaneous drug administration over durations, rates, and volumes that can be tailored to specific drugs. The pipeline includes Furosemide for heart failure, Ceftriaxone, and Ertapenem to treat bacterial infections.
Who are the top competitors of scPharmaceuticals?
What products or services does scPharmaceuticals offer?
scPharmaceuticals offers FUROSCIX.
Is scPharmaceuticals publicly traded?
Yes, scPharmaceuticals is publicly traded on NASDAQ under the ticker symbol SCPH.
Who are scPharmaceuticals's investors?
scPharmaceuticals has 6 investors. Key investors include MannKind Corp, Sun Pharma, Orbimed, 5AM Ventures, and Lundbeck Foundation.
What is scPharmaceuticals's ticker symbol?
The ticker symbol of scPharmaceuticals is SCPH on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.